Skip to main content

MNKD

Stock
Health Care
Biotechnology

Performance overview

MNKD Price
Price Chart

Forward-looking statistics

Beta
0.76
Risk
41.42%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.

Company info

SectorHealth Care
IndustryBiotechnology
Employees466
Market cap$1.3B

Fundamentals

Enterprise value—
Revenue—
Revenue per employee—
Profit margin—
Debt to equity—

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)—
Avg trading volume (10 day)—
Put-call ratio—

Macro factor sensitivity

Growth+1.2
Credit+6.8
Liquidity-0.8
Inflation-2.5
Commodities-0.4
Interest Rates-1.7

Valuation

Dividend yield0.00%
PEG Ratio—
Price to sales—
P/E Ratio25.62
Enterprise Value to Revenue—
Price to book—

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend day—

News

Top 3 Health Care Stocks That May Rocket Higher This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga (June 11, 2025)
MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates

MannKind (MNKD) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.05 per share a year ago.

Zacks Investment Research (May 8, 2025)
6 Favorite Biotech Bets For 2023

Biotechnology has often been among the most popular sectors in the MoneyShow Top Picks report, our annual survey of the nation's leading newsletter advisors. This year's report is no exception; here's a six-pack of favorite biotech ideas for the coming year.

Forbes (January 9, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free